BBY
42
2
RL
80
2
BXP
60
5
GE
72
4
MU
36
-6
AVY
54
-4
NKE
39
-3
AEP
58
4
ABBV
50
8
PFG
50
-2
ZION
69
-2
VNO
68
3
FDX
44
-2
UHS
62
6
NEM
44
-2
C
62
-3
V
72
-4
MRK
35
2
GS
78
3
UA
57
-8
BBY
42
2
RL
80
2
BXP
60
5
GE
72
4
MU
36
-6
AVY
54
-4
NKE
39
-3
AEP
58
4
ABBV
50
8
PFG
50
-2
ZION
69
-2
VNO
68
3
FDX
44
-2
UHS
62
6
NEM
44
-2
C
62
-3
V
72
-4
MRK
35
2
GS
78
3
UA
57
-8
Financhill
Back

NetEase Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
49

NTES
NetEase

Last Price:
87.12
Seasonality Move:
8.06%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Sell
49
NetEase (NTES) is a Sell

Is NetEase a Buy, Sell or Hold?

  • The current NetEase [NTES] share price is $86.21. The Score for NTES is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTES Stock Price Chart

What is NetEase's stock price today?

  • The NetEase share price today is $86.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.94 Buy
Relative Strength Index (14 RSI): 54.96 Buy
Chaikin Money Flow: 664232 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.33 - 85.65) Buy
Bollinger Bands (100): (79.51 - 92.77) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

NTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.71 Sell
20-day SMA: 82.38 Buy
50-day SMA: 85.04 Buy
200-day SMA: 92.62 Sell
8-day EMA: 85.63 Buy
20-day EMA: 84.08 Buy
50-day EMA: 84.35 Buy
200-day EMA: 90.09 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

NetEase Earnings Growth & NTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.61 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

NetEase Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):